Drug Information

Drug General Information
Drug ID
D0EV1L
Former ID
DIB016178
Drug Name
Elsiglutide
Synonyms
Tide ZP-1846; ZP-1846; GLP-2 analog (chemotherapy-induced diarrhoea), Zealand Pharma
Indication Diarrhea [ICD9: 787.91; ICD10:A09, K59.1] Phase 2 [523812]
Company
Zealand Pharma A/S
CAS Number
CAS 914009-84-0
Target and Pathway
Target(s) Glucagon-like peptide 2 receptor Target Info Modulator [550039]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome G alpha (s) signalling events
Glucagon-type ligand receptors
WikiPathways GPCRs, Class B Secretin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 523812ClinicalTrials.gov (NCT01543451) Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea. U.S. National Institutes of Health.
Ref 550039Poster Abstracts. Volume 10, Issue Supplement S8, pages 126-209, December 2014.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.